MedPath

To study the efficacy of narayan tail navan nasya in the management of Ardit wsrto Bell’s Palsy

Phase 2
Not yet recruiting
Conditions
Bells palsy. Ayurveda Condition: ARDITAH,
Registration Number
CTRI/2025/05/087833
Lead Sponsor
Dr Mrunal Anil Patil
Brief Summary

Randomised open control clinical study to evaluate the efficacy of Narayan Tail Nasya in Ardit w.s.r. to Bell’s Palsy study will be carried in panchkarma department opd at Yashwant Ayurved Medical College and hospital kodoli The Observation will be drawn on the basis of symptoms after treatment given

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Patients presenting sign and symptoms of ardita mukhavakrata netrastabdhata waksang lalasrav kshawathunigrah nasavakrata , Patient fit for nasya karma , Patient willing to give inform consent and able to participate in study.

Exclusion Criteria
  • Associated with any deformities or Fascial Fractures.
  • Patients under gone any major surgery.
  • Patients with other systemic disorders and Serious illness.
  • Having cardiovascular disease, Pulmonary TB Pregnancy HIV Acute Hemiplegia Acute Paraplegia.
  • CA related to face Subjects with hereditary disorders and Autoimmune disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Will check Reduced in waksang ashrusrava lalasrava mukhardha vakrata21days
Secondary Outcome Measures
NameTimeMethod
Complete cure in waksang ashrusrava lalasrava mukhardha vakrata21days

Trial Locations

Locations (1)

Yashwant ayurvedic college post graduate training and research centre Kodoli

🇮🇳

Kolhapur, MAHARASHTRA, India

Yashwant ayurvedic college post graduate training and research centre Kodoli
🇮🇳Kolhapur, MAHARASHTRA, India
Vd Mrunal Anil Patil
Principal investigator
9075516032
mrunalpatil2018@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.